ArticleScience translational medicine2025

Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia.

Nicola Maciocia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.